Biowave

Biowave’s neuromodulation pain therapy medical devices deliver a patented therapeutic electrical signal into deep tissue in the body which blocks the transmission of pain and improves function. Multiple clinical studies including double blinded randomized crossover studies have shown that a 20-30 minute treatment provides patients with significant benefits including:

• Up to an immediate 75% average reduction in pain
• 24 to 48 hours of pain relief
• Increase in range of motion
• Reduction of stiffness
• Reduction of muscle spasm

Biowave’s advanced, patented signal mixing technology allowed for the design of a very easy to use device – there is no programming – the signals coming out of the device are optimized for passing through the skin into deep tissue and for inhibiting pain transmission.

Additionally, Biowave’s SmartPAD™ technology is used in every electrode made by the Company. SmartPAD™ electrodes allow for the continuous monitoring and adjustment of the electrical signal technology ensuring the accurate and safe delivery of therapeutic energy into deep tissue.

All of Biowave’s neuromodulation pain therapy systems treat joint or muscular related chronic, acute or post-surgical pain in the low back, shoulder, neck, hip, knee, elbow, legs, arms, wrist, hands, ankles and feet, without harmful side effects. Use of Biowave devices reduces the need for morphine, narcotics and other painkillers, resulting in better quality of life scores.

Biowave’s patented percutaneous electrode array (PEA) is a microneedle patch technology that facilitates the delivery of high frequency electrical feed signals through the skin directly into deep tissue encompassing the pain site. The PEA eliminates impedance and capacitance issues associated with skinPercutaneous Electrode Array.